Antiretroviral therapy coverage for PMTCT in Paraguay
Paraguay: Antiretroviral therapy coverage for PMTCT was 52.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage for PMTCT in Paraguay, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.
Analysis
The most recent figure for antiretroviral therapy coverage for pmtct in Paraguay is 52.0%, measured in 2024.
Compared with earlier readings it is down 23.5% on the previous year and down 27.8% over ten years.
Over the whole period, antiretroviral therapy coverage for pmtct in Paraguay peaked at 84.0% in 2011 and was at its lowest, 0.0%, in 2000.
That places Paraguay 67th out of 84 countries with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage for PMTCT in Paraguay, year by year
| Year | % of pregnant women living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 71.0% | — |
| 2007 | 81.0% | +14.1% |
| 2008 | 82.0% | +1.2% |
| 2009 | 70.0% | -14.6% |
| 2010 | 70.0% | +0.0% |
| 2011 | 84.0% | +20.0% |
| 2012 | 74.0% | -11.9% |
| 2013 | 66.0% | -10.8% |
| 2014 | 72.0% | +9.1% |
| 2015 | 59.0% | -18.1% |
| 2016 | 68.0% | +15.3% |
| 2017 | 70.0% | +2.9% |
| 2018 | 69.0% | -1.4% |
| 2019 | 84.0% | +21.7% |
| 2020 | 70.0% | -16.7% |
| 2021 | 73.0% | +4.3% |
| 2022 | 69.0% | -5.5% |
| 2023 | 68.0% | -1.4% |
| 2024 | 52.0% | -23.5% |
Paraguay compared with similar countries
- Paraguay's 52.0% is below the median for upper middle income countries, which is 79.5%, 65% of the median. (22 countries reporting)
- Paraguay's 52.0% is below the median for Latin America & Caribbean, which is 68.0%, 76% of the median. (15 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 30.4% | 0.0% | 82.0% | 10 |
| 2010s | 71.6% | 59.0% | 84.0% | 10 |
| 2020s | 66.4% | 52.0% | 73.0% | 5 |
Countries ranked near Paraguay
More health data for Paraguay
- Un projection of annual infant deaths, annual growth rate -2.02 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.2374 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,098 deaths per 1,000 people (2090)
- Number of infants who die before age 1 339 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.5252 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0469 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.5185 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage for pmtct in Paraguay?
- Antiretroviral therapy coverage for pmtct in Paraguay was 52.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage for pmtct recorded in Paraguay?
- The highest recorded value was 84.0% in 2011.
- What is the lowest antiretroviral therapy coverage for pmtct recorded in Paraguay?
- The lowest recorded value was 0.0% in 2000.
- How does Paraguay rank for antiretroviral therapy coverage for pmtct?
- Paraguay ranks 67th out of 84 countries with data for 2024.
- Is antiretroviral therapy coverage for pmtct rising or falling in Paraguay?
- Over the last ten years it is down 27.8%. The long-run trend across the full record is volatile.
- Where does this Paraguay data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).